BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 16740690)

  • 21. MKK4 suppresses metastatic colonization by multiple highly metastatic prostate cancer cell lines through a transient impairment in cell cycle progression.
    Szmulewitz RZ; Clark R; Lotan T; Otto K; Taylor Veneris J; Macleod K; Rinker-Schaeffer C
    Int J Cancer; 2012 Feb; 130(3):509-20. PubMed ID: 21351092
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tuberous sclerosis-associated neoplasms express activated p42/44 mitogen-activated protein (MAP) kinase, and inhibition of MAP kinase signaling results in decreased in vivo tumor growth.
    Govindarajan B; Mizesko MC; Miller MS; Onda H; Nunnelley M; Casper K; Brat D; Cohen C; Arbiser JL
    Clin Cancer Res; 2003 Aug; 9(9):3469-75. PubMed ID: 12960139
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanism of p38 MAP kinase activation in vivo.
    Brancho D; Tanaka N; Jaeschke A; Ventura JJ; Kelkar N; Tanaka Y; Kyuuma M; Takeshita T; Flavell RA; Davis RJ
    Genes Dev; 2003 Aug; 17(16):1969-78. PubMed ID: 12893778
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Time-dependent transcriptional profiling links gene expression to mitogen-activated protein kinase kinase 4 (MKK4)-mediated suppression of omental metastatic colonization.
    Bainer RO; Veneris JT; Yamada SD; Montag A; Lingen MW; Gilad Y; Rinker-Schaeffer CW
    Clin Exp Metastasis; 2012 Jun; 29(5):397-408. PubMed ID: 22350525
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inserting chromosome 18 into pancreatic cancer cells switches them to a dormant metastatic phenotype.
    Lefter LP; Sunamura M; Furukawa T; Takeda K; Kotobuki N; Oshimura M; Matsuno S; Horii A
    Clin Cancer Res; 2003 Oct; 9(13):5044-52. PubMed ID: 14581380
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutation rate of MAP2K4/MKK4 in breast carcinoma.
    Su GH; Song JJ; Repasky EA; Schutte M; Kern SE
    Hum Mutat; 2002 Jan; 19(1):81. PubMed ID: 11754110
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumor growth suppression in pancreatic cancer by a putative metastasis suppressor gene Cap43/NDRG1/Drg-1 through modulation of angiogenesis.
    Maruyama Y; Ono M; Kawahara A; Yokoyama T; Basaki Y; Kage M; Aoyagi S; Kinoshita H; Kuwano M
    Cancer Res; 2006 Jun; 66(12):6233-42. PubMed ID: 16778198
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functional analysis of chromosome 18 in pancreatic cancer: strong evidence for new tumour suppressor genes.
    Lefter LP; Sunamura M; Furukawa T; Yastsuoka T; Abe H; Inoue H; Abe T; Egawa S; Miura K; Morita R; Horii A; Matsuno S
    Asian J Surg; 2004 Apr; 27(2):85-92. PubMed ID: 15140658
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Green fluorescent protein tagging of extracellular signal-regulated kinase and p38 pathways reveals novel dynamics of pathway activation during primary and metastatic growth.
    Aguirre-Ghiso JA; Ossowski L; Rosenbaum SK
    Cancer Res; 2004 Oct; 64(20):7336-45. PubMed ID: 15492254
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mitogen-activated protein kinase kinase 4/c-Jun NH2-terminal kinase kinase 1 protein expression is subject to translational regulation in prostate cancer cell lines.
    Robinson VL; Shalhav O; Otto K; Kawai T; Gorospe M; Rinker-Schaeffer CW
    Mol Cancer Res; 2008 Mar; 6(3):501-8. PubMed ID: 18337456
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Roles of JNK, p38 and ERK mitogen-activated protein kinases in the growth inhibition and apoptosis induced by cadmium.
    Chuang SM; Wang IC; Yang JL
    Carcinogenesis; 2000 Jul; 21(7):1423-32. PubMed ID: 10874022
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Restoration of p53 functions suppresses tumor growth of pancreatic cells with different p53 status.
    Taghavi MH; Davoodi J
    Cancer Biother Radiopharm; 2007 Jun; 22(3):322-32. PubMed ID: 17651038
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of SRC expression and activity inhibits tumor progression and metastasis of human pancreatic adenocarcinoma cells in an orthotopic nude mouse model.
    Trevino JG; Summy JM; Lesslie DP; Parikh NU; Hong DS; Lee FY; Donato NJ; Abbruzzese JL; Baker CH; Gallick GE
    Am J Pathol; 2006 Mar; 168(3):962-72. PubMed ID: 16507911
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PKR regulates TLR2/TLR4-dependent signaling in murine alveolar macrophages.
    Cabanski M; Steinmüller M; Marsh LM; Surdziel E; Seeger W; Lohmeyer J
    Am J Respir Cell Mol Biol; 2008 Jan; 38(1):26-31. PubMed ID: 17690330
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MKK4 status predicts survival after resection of gastric adenocarcinoma.
    Cunningham SC; Kamangar F; Kim MP; Hammoud S; Haque R; Iacobuzio-Donahue C; Ashfaq R; Kern SE; Maitra A; Heitmiller RE; Choti MA; Lillemoe KD; Cameron JL; Yeo CJ; Montgomery E; Schulick RD
    Arch Surg; 2006 Nov; 141(11):1095-9; discussion 1100. PubMed ID: 17116802
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium.
    Lerman MI; Minna JD
    Cancer Res; 2000 Nov; 60(21):6116-33. PubMed ID: 11085536
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Norepinephrine stimulates pancreatic cancer cell proliferation, migration and invasion via β-adrenergic receptor-dependent activation of P38/MAPK pathway.
    Huang XY; Wang HC; Yuan Z; Huang J; Zheng Q
    Hepatogastroenterology; 2012 May; 59(115):889-93. PubMed ID: 22020907
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A CK2-dependent mechanism for degradation of the PML tumor suppressor.
    Scaglioni PP; Yung TM; Cai LF; Erdjument-Bromage H; Kaufman AJ; Singh B; Teruya-Feldstein J; Tempst P; Pandolfi PP
    Cell; 2006 Jul; 126(2):269-83. PubMed ID: 16873060
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic deletion of PKR abrogates TNF-induced activation of IkappaBalpha kinase, JNK, Akt and cell proliferation but potentiates p44/p42 MAPK and p38 MAPK activation.
    Takada Y; Ichikawa H; Pataer A; Swisher S; Aggarwal BB
    Oncogene; 2007 Feb; 26(8):1201-12. PubMed ID: 16924232
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional parsing of driver mutations in the colorectal cancer genome reveals numerous suppressors of anchorage-independent growth.
    Eskiocak U; Kim SB; Ly P; Roig AI; Biglione S; Komurov K; Cornelius C; Wright WE; White MA; Shay JW
    Cancer Res; 2011 Jul; 71(13):4359-65. PubMed ID: 21527559
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.